Identification of genetic subtypes in follicular lymphoma

被引:6
作者
Shelton, Victoria [1 ]
Detroja, Rajesh [1 ]
Liu, Ting [1 ]
Isaev, Keren [1 ]
Silva, Anjali [1 ,2 ]
Passerini, Verena [3 ]
Bakhtiari, Mehran [1 ]
Calvente, Lourdes [1 ]
Hong, Michael [1 ]
He, Michael Y. [1 ]
Modi, Saloni [1 ]
Hershenfeld, Samantha A. [1 ]
Ludvigsen, Maja [4 ,5 ]
Madsen, Charlotte [5 ]
Hamilton-Dutoit, Stephen [6 ]
d'Amore, Francesco Annibale [4 ,5 ]
Brodtkorb, Marianne [7 ]
Johnson, Nathalie A. [8 ]
Baetz, Tara [9 ]
LeBrun, David [10 ]
Tobin, Josh W. D. [11 ,12 ]
Gandhi, Maher K. [11 ,12 ]
Mungall, Andrew J. [13 ]
Xu, Wei [14 ]
Ben-Neriah, Susana [15 ]
Steidl, Christian [15 ]
Delabie, Jan [16 ]
Tremblay-LeMay, Rosemarie [16 ]
Jegede, Opeyemi [17 ]
Weigert, Oliver [3 ,18 ,19 ]
Kahl, Brad [20 ]
Evens, Andrew M. [21 ]
Kridel, Robert [1 ]
机构
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Vector Inst, Toronto, ON, Canada
[3] Ludwig Maximilians Univ LMU Hosp, Dept Internal Med 3, Munich, Germany
[4] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
[5] Aarhus Univ Hosp, Dept Hematol, Aarhus, Denmark
[6] Aarhus Univ Hosp, Dept Pathol, Aarhus, Denmark
[7] Oslo Univ Hosp, Dept Oncol, Oslo, Norway
[8] Jewish Gen Hosp, Montreal, PQ, Canada
[9] Queens Univ, Dept Oncol, Kingston, ON, Canada
[10] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada
[11] Mater Res Univ Queensland, Brisbane, Qld, Australia
[12] Princess Alexandra Hosp, Dept Haematol, Brisbane, Qld, Australia
[13] Canadas Michael Smith Genome Sci Ctr BC Canc, Vancouver, BC, Canada
[14] Univ Toronto, Princess Margaret Canc Ctr, Dalla Lana Sch Publ Hlth, Dept Biostat, Toronto, ON, Canada
[15] BC Canc, Vancouver, BC, Canada
[16] Univ Hlth Network, Lab & Med Program, Toronto, ON, Canada
[17] Dana Farber Canc Inst, Boston, MA USA
[18] German Canc Consortium DKTK, Munich, Germany
[19] German Canc Res Ctr, Heidelberg, Germany
[20] Washington Univ, St. Louis, MO USA
[21] Rutgers Canc Inst, New Brunswick, NJ USA
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
HIGH-RISK; EXPRESSION; VALIDATION; MUTATIONS; CLASSIFICATION; TRANSFORMATION; PATHOGENESIS; PROGRESSION; ACTIVATION; PREDICTION;
D O I
10.1038/s41408-024-01111-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Follicular lymphoma (FL) exhibits considerable variability in biological features and clinical trajectories across patients. To dissect the diversity of FL, we utilized a Bernoulli mixture model to identify genetic subtypes in 713 pre-treatment tumor tissue samples. Our analysis revealed the existence of five subtypes with unique genetic profiles that correlated with clinicopathological characteristics. The clusters were enriched in specific mutations as follows: CS (CREBBP and STAT6), TT (TNFAIP3 and TP53), GM (GNA13 and MEF2B), Q (quiescent, for low mutation burden), and AR (mutations of mTOR pathway-related genes). The subtype Q was enriched for patients with stage I disease and associated with a lower proliferative history than the other subtypes. The AR subtype was unique in its enrichment for IgM-expressing FL cases and was associated with advanced-stage and more than 4 nodal sites. The existence of subtypes was validated in an independent cohort of 418 samples from the GALLIUM trial. Notably, patients assigned to the TT subtype consistently experienced inferior progression-free survival when treated with immunochemotherapy. Our findings offer insight into core pathways distinctly linked with each FL cluster and are expected to be informative in the era of targeted therapies.
引用
收藏
页数:13
相关论文
共 45 条
[1]   DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma [J].
Amin, Rada ;
Mourcin, Frederic ;
Uhel, Fabrice ;
Pangault, Celine ;
Ruminy, Philippe ;
Dupre, Loic ;
Guirriec, Marion ;
Marchand, Tony ;
Fest, Thierry ;
Lamy, Thierry ;
Tarte, Karin .
BLOOD, 2015, 126 (16) :1911-1920
[2]   Epidemiology of the non-Hodgkin's lymphomas: Distributions of the major subtypes differ by geographic locations [J].
Anderson, JR ;
Armitage, JO ;
Weisenburger, DD .
ANNALS OF ONCOLOGY, 1998, 9 (07) :717-720
[3]   Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering [J].
Arora, Arshi ;
Olshen, Adam B. ;
Seshan, Venkatraman E. ;
Shen, Ronglai .
GENOME MEDICINE, 2020, 12 (01)
[4]  
Benjamin D., 2019, Calling Somatic SNVs and Indels with Mutect2, P1, DOI [DOI 10.1101/861054, 10.1101/861054v1, DOI 10.1101/861054V1]
[5]   Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma [J].
Bolen, Christopher R. ;
Mattiello, Federico ;
Herold, Michael ;
Hiddemann, Wolfgang ;
Huet, Sarah ;
Klapper, Wolfram ;
Marcus, Robert ;
Mir, Farheen ;
Salles, Gilles ;
Weigert, Oliver ;
Nielsen, Tina ;
Oestergaard, Mikkel Z. ;
Venstrom, Jeffrey M. .
BLOOD, 2021, 137 (19) :2704-2707
[6]   Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma [J].
Burack, W. Richard ;
Li, Hongli ;
Adlowitz, Diana ;
Spence, Janice M. ;
Rimsza, Lisa M. ;
Shadman, Mazyar ;
Spier, Catherine M. ;
Kaminski, Mark S. ;
Leonard, John P. ;
Leblanc, Michael L. ;
Smith, Sonali M. ;
Friedberg, Jonathan W. .
BLOOD ADVANCES, 2023, 7 (17) :5082-5090
[7]   Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials [J].
Casulo, Carla ;
Dixon, Jesse G. ;
Le-Rademacher, Jennifer ;
Hoster, Eva ;
Hochster, Howard S. ;
Hiddemann, Wolfgang ;
Marcus, Robert ;
Kimby, Eva ;
Herold, Michael ;
Sebban, Catherine ;
Gyan, Emmanuel ;
Foon, Kenneth ;
Nielsen, Tina ;
Vitolo, Umberto ;
Salles, Gilles A. ;
Shi, Qian ;
Flowers, Christopher R. .
BLOOD, 2022, 139 (11) :1684-1693
[8]   Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study [J].
Casulo, Carla ;
Byrtek, Michelle ;
Dawson, Keith L. ;
Zhou, Xiaolei ;
Farber, Charles M. ;
Flowers, Christopher R. ;
Hainsworth, John D. ;
Maurer, Matthew J. ;
Cerhan, James R. ;
Link, Brian K. ;
Zelenetz, Andrew D. ;
Friedberg, Jonathan W. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (23) :2516-U55
[9]   Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes [J].
Chapuy, Bjoern ;
Stewart, Chip ;
Dunford, Andrew J. ;
Kim, Jaegil ;
Kamburov, Atanas ;
Redd, Robert A. ;
Lawrence, Mike S. ;
Roemer, Margaretha G. M. ;
Li, Amy J. ;
Ziepert, Marita ;
Staiger, Annette M. ;
Wala, Jeremiah A. ;
Ducar, Matthew D. ;
Leshchiner, Ignaty ;
Rheinbay, Ester ;
Taylor-Weiner, Amaro ;
Coughlin, Caroline A. ;
Hess, Julian M. ;
Pedamallu, Chandra S. ;
Livitz, Dimitri ;
Rosebrock, Daniel ;
Rosenberg, Mara ;
Tracy, Adam A. ;
Horn, Heike ;
van Hummelen, Paul ;
Feldman, Andrew L. ;
Link, Brian K. ;
Novak, Anne J. ;
Cerhan, James R. ;
Habermann, Thomas M. ;
Siebert, Reiner ;
Rosenwald, Andreas ;
Thorner, Aaron R. ;
Meyerson, Matthew L. ;
Golub, Todd R. ;
Beroukhim, Rameen ;
Wulf, Gerald G. ;
Ott, German ;
Rodig, Scott J. ;
Monti, Stefano ;
Neuberg, Donna S. ;
Loeffler, Markus ;
Pfreundschuh, Michael ;
Truemper, Lorenz ;
Getz, Gad ;
Shipp, Margaret A. .
NATURE MEDICINE, 2018, 24 (05) :679-+
[10]   Molecular subclusters of follicular lymphoma: a report from the United Kingdom?s Haematological Malignancy Research Network [J].
Crouch, Simon ;
Painter, Daniel ;
Barrans, Sharon L. ;
Roman, Eve ;
Beer, Philip A. ;
Cooke, Susanna L. ;
Glover, Paul ;
Webster, Nichola ;
Lacy, Stuart E. ;
Ruiz, Camilo ;
Campbell, Peter J. ;
Hodson, Daniel J. ;
Patmore, Russell ;
Burton, Cathy ;
Smith, Alexandra ;
Tooze, Reuben M. .
BLOOD ADVANCES, 2022, 6 (21) :5716-5731